OA03 Afatinib Followed by Osimertinib in Real-World Patients With EGFR Mutation-Positive Advanced NSCLC: The Giotag Study
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.013
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Elsevier BV